SCHEMBL6711568

SCHEMBL6711568

CCOC(=O)C(Cc1ccc(C)cc1)C(=O)OCC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 1/20 0.57
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
ALDH1A1 P00352 4/20 0.50
TP53 P04637 1/20 0.50
LDHA P00338 1/20 0.46
NPY1R P25929 1/20 0.46
NPY2R P49146 1/20 0.46
PKM P14618 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
LMNA P02545 2/20 0.44
MAPT P10636 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
HPGD P15428 1/20 0.44
ALOX12 P18054 1/20 0.44
STAT3 P40763 1/20 0.44
HTT P42858 1/20 0.44
KCNH2 Q12809 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PTPRB P23467 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1312803 0.94 MMP8 (0.62) MMP8MEN1KMT2AALDH1A1TP53
SCHEMBL5326604 0.91 MMP8 (0.53) MMP8MEN1KMT2AALDH1A1TP53
SCHEMBL18946161 0.87 MMP8 (0.59) MMP8ALDH1A1TP53LDHANPY1R
SCHEMBL5800254 0.87 MMP8 (0.55) MMP8ALDH1A1TP53LDHANPY1R
SCHEMBL15726083 0.87 MMP8 (0.49) MMP8MEN1KMT2AALDH1A1TP53
SCHEMBL27747 0.85 MMP8 (0.58) MMP8MEN1KMT2AALDH1A1TP53
SCHEMBL2672619 0.85 MMP8 (0.54) MMP8ALDH1A1TP53NPY1RNPY2R
SCHEMBL1437676 0.85 MMP8 (0.54) MMP8MEN1KMT2AALDH1A1TP53
SCHEMBL7436472 0.85 MMP8 (0.54) MMP8MEN1KMT2AALDH1A1TP53
SCHEMBL7260547 0.85 MMP8 (0.54) MMP8MEN1KMT2AALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010116270-A1 EP2/4 AGONISTS PFIZER INC. (US) 2010-10-14 WO disclosed
US-20040063729-A1 Microbiocides BAYER CROPSCIENCE K. K. (JP) 2004-04-01 US disclosed
EP-1345940-A2 TRIAZOLOPYRIMIDINES Bayer CropScience K.K. (JP) 2003-09-24 EP disclosed
WO-2002051845-A2 TRIAZOLOPYRIMIDINES BAYER CROPSCIENCE K.K. (DE) 2002-07-04 WO disclosed
EP-0050671-B1 THIAZOLO(3,2-A)PYRIMIDINE DERIVATIVES, PROCESS FOR PREPARING SAME, AND DRUG CONTAINING SAME TEIJIN LIMITED (JP) 1985-03-20 EP disclosed
US-4383996-A IMMUNOREGULATOR TEIJIN LIMITED (JP) 1983-05-17 US disclosed
EP-0050671-A1 THIAZOLO(3,2-a)PYRIMIDINE DERIVATIVES, PROCESS FOR PREPARING SAME, AND DRUG CONTAINING SAME TEIJIN LIMITED (JP) 1982-05-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063729-A1 Microbiocides FPR1, MPO, FPR2 MMP8 155/4885MEN1 4229/4885KMT2A 3155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.